ECP
Elk Creek Partners Portfolio holdings
AUM
$582M
This Quarter Return
-3.28%
1 Year Return
-10.23%
3 Year Return
+16.51%
5 Year Return
+41.71%
10 Year Return
–
AUM
$1.16B
AUM Growth
+$1.16B
(-13%)
Cap. Flow
-$90.1M
Cap. Flow
% of AUM
-7.75%
Top 10 Holdings %
Top 10 Hldgs %
23.85%
Holding
127
New
3
Increased
41
Reduced
72
Closed
11
Top Buys
| 1 |
Karyopharm Therapeutics
KPTI
|
$12.2M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$10.7M |
| 3 |
Ligand Pharmaceuticals
LGND
|
$10M |
| 4 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$9.42M |
| 5 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$8.04M |
Top Sells
| 1 |
WAGE
WageWorks, Inc.
WAGE
|
$21M |
| 2 |
MasTec
MTZ
|
$15M |
| 3 |
MDCO
Medicines Co
MDCO
|
$13.7M |
| 4 |
EFII
Electronics for Imaging
EFII
|
$13.2M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
$12.2M |
Sector Composition
| 1 | Healthcare | 27.95% |
| 2 | Technology | 17.01% |
| 3 | Industrials | 12.32% |
| 4 | Consumer Discretionary | 11.44% |
| 5 | Communication Services | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
PTC Therapeutics
PTCT
$3.92B
| $12.4M | 1.07% | 366,636 +76,486 | +26% | +$2.59M |
|
|
NXGN
27
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $12.2M | 1.05% | 781,647 -124,994 | -14% | -$1.96M |
|
|
28
Karyopharm Therapeutics
KPTI
$61.7M
| $12.2M | 1.05% | +1,270,723 | New | +$12.2M |
|
29
Exact Sciences
EXAS
$8.98B
| $12.2M | 1.05% | 134,682 -1,300 | -1% | -$117K |
|
|
AMRN
30
Amarin Corp
AMRN
$311M
| $12.1M | 1.04% | 798,824 +263,415 | +49% | +$3.99M |
|
|
MAXR
31
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $12.1M | 1.04% | 1,592,748 -7,657 | -0.5% | -$58.2K |
|
|
CLVS
32
DELISTED
Clovis Oncology, Inc.
CLVS
| $12.1M | 1.04% | 3,073,550 +2,046,575 | +199% | +$8.04M |
|
33
EnerSys
ENS
$3.85B
| $12M | 1.03% | 181,952 +54,904 | +43% | +$3.62M |
|
34
Medifast
MED
$154M
| $11.9M | 1.03% | 115,300 +44,880 | +64% | +$4.65M |
|
|
WWE
35
DELISTED
World Wrestling Entertainment
WWE
| $11.9M | 1.03% | 167,822 +8,721 | +5% | +$621K |
|
36
Acadia Healthcare
ACHC
$2.12B
| $11.9M | 1.03% | 383,854 +19,657 | +5% | +$611K |
|
37
Halozyme
HALO
$8.56B
| $11.8M | 1.01% | 758,553 -51,402 | -6% | -$797K |
|
|
MTOR
38
DELISTED
MERITOR, Inc.
MTOR
| $11.7M | 1% | 630,980 +39,268 | +7% | +$726K |
|
|
WAAS
39
DELISTED
AquaVenture Holdings Limited
WAAS
| $11.6M | 1% | 597,437 +48,427 | +9% | +$941K |
|
40
Heron Therapeutics
HRTX
$207M
| $11.6M | 1% | 625,636 -42,604 | -6% | -$788K |
|
|
PTLA
41
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $11.6M | 0.99% | 430,825 +13,236 | +3% | +$355K |
|
42
Zurn Elkay Water Solutions
ZWS
$7.6B
| $11M | 0.95% | 407,069 -38,132 | -9% | -$1.03M |
|
|
ICPT
43
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $10.7M | 0.92% | +161,406 | New | +$10.7M |
|
|
TCF
44
DELISTED
TCF Financial Corporation Common Stock
TCF
| $10.4M | 0.9% | 273,515 +17,111 | +7% | +$651K |
|
45
Enerpac Tool Group
EPAC
$2.28B
| $10.3M | 0.88% | 469,064 +11,003 | +2% | +$241K |
|
46
National Vision
EYE
$1.82B
| $10.2M | 0.88% | 424,595 +65,083 | +18% | +$1.57M |
|
47
Kinsale Capital Group
KNSL
$10.7B
| $10.1M | 0.87% | 98,100 -31,984 | -25% | -$3.3M |
|
48
Surgery Partners
SGRY
$2.91B
| $10.1M | 0.87% | 1,366,741 -87,686 | -6% | -$648K |
|
|
49
MasTec
MTZ
$14.3B
| $10M | 0.86% | 154,731 -230,474 | -60% | -$15M |
|
50
NN Inc
NNBR
$129M
| $9.54M | 0.82% | 1,337,366 -60,579 | -4% | -$432K |
|